In vitro and in vivo evaluation of insulin microspheres containing protease inhibitor

Abstract

The aim of this study was to investigate the applicability of microspheres containing protease inhibitor for oral delivery of insulin (CAS 9004-10-8). Microspheres of insulin were prepared by water-in-oil-in-oil (w/o₁/o₂) double emulsion solvent evaporation method. Formulations with different drug/polymer ratios were prepared and characterized by drug loading, loading efficiency, yield, particle size, scanning electron microscopy (SEM), Fourier Transform Infrared spectroscopy (FTIR). The in vitro release studies were performed in pH 1.2 and 7.4. In vivo studies on rats were conducted in order to investigate the bioavailability and performance of oral microspheres. The best polymer to drug ratio in microspheres was 15.6:1 (F₂ formulation). The loading efficiency was 77.36%, production yield was 54.55% and mean particle size was 222.4 μm. SEM studies showed that the microspheres were spherical and porous in nature. Data obtained from in vitro release were fitted to various kinetic models and high correlation was obtained in the first order model. The results of enzymatic degradation indicated that insulin could be protected from trypsinic degradation in the microspheres. Our results indicate that the microspheres containing aprotinin (CAS 9087–70-1) have the advantage of high loading efficiency, pH responsive and prolonged release carrying insulin to the optimum site of absorption as well as the enhanced insulin absorption and biological response.

Key words

Double-emulsion solvent diffusion - Enzymatic degradation - Insulin - Microspheres - Oral delivery - Protease inhibitor

• References

• 1 Cunha AS, Grossiord JL, Puisieux F, Seiller M. Insulin in w/o/w multiple emulsions: preparation characterization and determination of stability towards proteases in vitro. J Microencapsul. 1997; 14 (3) 311-9
• 2 Engel RH, Riggi SI, Fahrenbach MJ. Insulin: intestinal absorption as water-in-oil-in-water emulsions. Nature. 1968; 219 (5156) 856-7
• 3 Schilling RJ, Mitra AK. Intestinal mucosal transport of insulin. Pharm Res. 1990; 62 (1) 53-64
• 4 Fujii S, Yokoyama T, Ikegaya K, Sato F, Yokoo N. Promoting effect of the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats and dogs. J Pharm Pharmacol. 1985; 37 (8) 545-9
• 5 Kidron M, Bar-On H, Berry EM, Ziv E. The absorption of insulin from various regions of the rat intestine. Life Sci. 1982; 31 (25) 2837-41
• 6 Ziv E, Lior O, Kidron M. Absorption of protein via the intestinal wall. A quantitative model. Biochem Pharmacol. 1987; 36 (7) 1035-9
• 7 Morishita I, Morishita M, Takayama K, Machida Y, Nagai T. Hypoglycemic effect of novel oral microspheres of insulin with protease inhibitor in normal and diabetic rats. Int J Pharm. 1992; 78 (1) 9-16
• 8 Morishita M, Morishita I, Takayama K, Machida Y, Nagai T. Novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation.novel oral microspheres of insulin with protease inhibitor protecting from enzymatic degradation. Int J Pharm. 1992; 78 (1-3) 1-7
• 9 Narayani R. Oral delivery of insulin making needles needless. Trends Biomater Artif Organs. 2001; 15: 12-6
• 10 Kimura T, Sato K, Sugimoto K, Tao R, Murakami T, Kurosaki Y, Nakayama T. Oral administration of insulin as poly(vinyl alcohol)-gel spheres in diabetic rats. Biol Pharm Bull. 1996; 19 (6) 897-900
• 11 Morishita I, Morishita M, Takayama K, Machida Y, Nagai T. Enteral insulin delivery by microspheres in 3 different formulations using Eudragit-L100 and Eudragit-S100. Int J Pharm. 1993; 91 (1) 29-37
• 12 Suzuki A, Morishita M, Kajita M, Takayama K, Isowa K, Chiba Y et al. Enhanced colonic and rectal absorption of insulin using a multiple emulsion containing eicosapentaenoic acid and docosahexaenoic acid. J Pharm Sci. 1998; 87 (10) 1196-202
• 13 Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs. 1985; 29 (3) 236-61
• 14 Kraeling ME, Ritschel WA. Development of a colonic release capsule dosage form and the absorption of insulin. Methods Find Exp Clin Pharmacol. 1992; 14 (3) 199-209
• 15 Morishita I, Morishita M, Machida Y, Nagai T. Controlled release microspheres based on Eudragit L100 for the oral administration of erythromycin. Drug Des Deliv. 1991; 7 (4) 309-19
• 16 Jelvehgari M, Valizadeh H, Rezapour M, Nokhodchi A. Control of encapsulation efficiency in polymeric microparticle system of tolmetin. Pharm Dev Technol. 2010; 15 (1) 71-9
• 17 Jelvehgari M, Rezapour M, Nokhodchi A, Valizadeh H. Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method. Ind J Pharm Sci. 2010; 72 (1) 72-8
• 18 Kilicarslan M, Baykara T. The effect of the drug/polymer ratio on the properties of the verapamil HCl loaded microspheres. Int J Pharm. 2003; 252 (1-2) 99-109
• 19 Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, Mohammadi G, Danesh-Bahreini MA, Adibkia K et al. Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev Ind Pharm. 2007; 33 (1) 45-56
• 20 Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D et al. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm. 2004; 30 (3) 303-17
• 21 Monajjemzadeh F, Hassanzadeh D, Valizadeh H, Siahi-Shadbad MR, Mojarrad JS, Robertson TA et al. Compatibility studies of acyclovir and lactose in physical mixtures and commercial tablets. Eur J Pharm Biopharm. 2009; 73 (3) 404-13
• 22 Monajjemzadeh F, Hassanzadeh D, Valizadeh H, Siahi-Shadbad MR, Mojarrad JS, Robertson T et al. Assessment of feasibility of maillard reaction between baclofen and lactose by liquid chromatography and tandem mass spectrometry, application to pre formulation studies. AAPS PharmSciTech. 2009; 10 (2) 649-59
• 23 Barzegar-Jalali M, Nayebi AM, Valizadeh H, Hanaee J, Barzegar-Jalali A, Adibkia K et al. Evaluation of in vitroin vivo correlation and anticonvulsive effect of carbamazepine after cogrinding with microcrystalline cellulose. J Pharm Pharm Sci. 2006; 9 (3) 307-16
• 24 http://www.thermo.com/com/cda/resources/resources-detail/1,2166,13411,00.html 2009.
• 25 Shingel KI. Determination of structural peculiarities of dexran, pullulan and gamma-irradiated pullulan by Fourier-transform IR spectroscopy. Carbohydr Res. 2002; 337 (16) 1445-51
• 26 Li MG, Lu WL, Wang JC, Zhang X, Zhang H, Wang XQ et al. Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate/methyl-methacrylic acid) copolymer. J Nanosci Nanotechnol. 2006; 6 (9–10) 2874-86
• 27 Jain D, Panda AK, Majumdar DK. Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech. 2005; 6 (1) E100-7
• 28 Dastmalchi S, Garjani A, Maleki N, Sheikhee G, Baghchevan V, Jafari-Azad P et al. Enhancing dissolution, serum concentrations and hypoglycemic effect of glibenclamide using solvent deposition technique. J Pharm Pharm Sci. 2005; 8 (2) 175-81
• 29 Damge C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release. 2007; 117 (2) 163-70
• 30 Ernest D, Alfert E, Brenda M, Cross BM, McWilliam AAE. CCAC, Guide to the care and use of experimental animals. Canadian Council on Animal Care 1993;
• 31 Dong A, Huang P, Caughey WS. Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry. 1990; 29 (13) 3303-8
• 32 Susi H, Byler DM. Protein structure by Fourier transform infrared spectroscopy: second derivative spectra. Biochem Biophys Res Commun. 1983; 115 (1) 391-7
• 33 Rastogi SK, Singh J. Passive and iontophoretic transport enhancement of insulin through porcine epidermis by depilatories: permeability and fourier transform infrared spectroscopy studies. AAPS Pharm Sci Tech. 2003; 4 (3) E29
• 34 Jameela SR, Suma N, Jayakrishnan A. Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study. J Biomater Sci Polym Ed. 1997; 8 (6) 457-66
• 35 Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Technol. 1996; 20: 64-74
• 36 Nokhodchi A, Okwudarue ON, Valizadeh H, Momin MN. Cogrinding as a tool to produce sustained release behavior for theophylline particles containing magnesium stearate. AAPS PharmSciTech. 2009; 10 (4) 1243-51
• 37 Nokhodchi A, Nazemiyeh H, Khodaparast A, Sorkh-Shahan T, Valizadeh H, Ford JL. An in vitro evaluation of fenugreek mucilage as a potential excipient for oral controlled-release matrix tablet. Drug Dev Ind Pharm. 2008; 34 (3) 323-9
• 38 Barzegar-Jalali M, Adibkia K, Valizadeh H, Shadbad MR, Nokhodchi A, Omidi Y et al. Kinetic analysis of drug release from nanoparticles. J Pharm Pharm Sci. 2008; ll (1) 167-77
• 39 Azarmi S, Farid J, Nokhodchi A, Bahari-Saravi SM, Valizadeh H. Thermal treating as a tool for sustained release of indomethacin from Eudragit RS and RL matrices. Int J Pharm. 2002; 246 (1-2) 171-7
• 40 Paquot N, Scheen AJ, Franchimont P, Lefebvre PJ. The intra-nasal administration of insulin induces significant hypoglycemia and classical counterregulatory hormonal responses in normal man. Diabetes Metab. 1988; 14 (1) 31-6